Welcome!

News Feed Item

Taconic and CERBM-IGBMC Collaborate to Offer Cre-ERT Technology for Inducible Gene Targeting in Genetically Modified Rodents

HUDSON, NY -- (Marketwired) -- 07/10/14 -- Taconic and Le Centre Européen de Recherche en Biologie et en Médecine - Institut de Génétique et de Biologie Moléculaire et Cellulaire (CERBM-IGBMC) today announced a global cross-licensing agreement to improve access to Cre-ERT technology for inducible gene targeting in genetically engineered rodents. Under the agreement each party will be able to generate, sell and use Cre-ERT mouse lines for Tamoxifen induction experiments. Further, Taconic will play a role in helping companies acquire needed rights from CERBM-IGBMC to perform induction studies in Cre-ERT gene targeted mouse lines. Taconic and CERBM-IGBMC are the only fully licensed service providers of the Cre-ERT technology. Combining the access rights to both patent families is specifically important because it equips researchers to explore gene function in adult mice.

Cre-ERT technology was developed independently by scientists at two organizations: Francis Stewart at the European Molecular Biology Laboratory (EMBL) as well as Pierre Chambon and Daniel Metzger at the CERBM-IGBMC. Taconic is the exclusive commercial license holder of the EMBL patent portfolio broadly covering the use of ligand-dependent site-specific recombinases. The CERBM-IGBMC patents cover methods for performing inducible gene targeting in transgenic mice expressing a Cre-ERT fusion protein. The method employs administration of Tamoxifen to transgenic mice to induce Cre-mediated recombination.

The agreement by Taconic and CERBM-IGBMC to further develop and provide access to Cre-ERT technology addresses key challenges relating to understanding cancer, metabolic disorders, stroke and other diseases. "We are very pleased to partner with CERBM-IGBMC to further develop the effective application of Cre-ERT technology in genetically engineered mouse models," stated Todd Little, President of Taconic. "Cre-ERT technology is a powerful tool for studying gene function and expression in many tissues."

The agreement also enhances both organizations' efforts to bring better, more predictive mouse models to market for use by scientists worldwide. "We have greatly contributed to the development and success of the 'Cre-ERT' technology, and will continue to make it freely available to the academic scientific community," said Professor Chambon at the CERBM-IGBMC. "We are very happy with this agreement, and hope that it will contribute to the generation of several new mouse models of human diseases for use in drug discovery and development," said Dr. Daniel Metzger at the CERBM-IGBMC.

About Taconic
Taconic is a global provider of genetically engineered mouse and rat models and services. As a full-service industry leader, founded in 1952, Taconic helps clients acquire, test, develop, breed, cryopreserve, prepare, and distribute highly relevant research lines worldwide. Headquartered in New York's Hudson River Valley, Taconic operates six breeding facilities and three service laboratories in the U.S. and Europe and maintains over 850 employees committed to technological innovation. Taconic's products and services are used by over 1300 companies and academic research institutions in nearly 50 nations worldwide. Learn more at http://www.taconic.com

About the Centre Européen en Biology et Médecine (CERBM) and the Institute of Genetics and Molecular and Cellular Biology (IGBMC).
The Institute of Genetics and Molecular and Cellular Biology (IGBMC) which was created in 1994 by Pierre Chambon is one of the main European centers of biomedical research that combines, within the CERBM-IGBMC, Units of the INSERM, the CNRS and the University of Strasbourg. Besides four scientific departments, the CERBM-IGBMC includes scientific services and advanced technological platforms, such as the Mouse Clinical Institute (ICS), which are also open to the external scientific community. The objective of the CERBM-IGBMC is to develop multidisciplinary research interfacing biology, genetics, biochemistry, physics and medicine, and also to attract students and post-doctoral fellows from all around the world by offering high-level training in the field of biomedical sciences.

About the Cre-ERT technology
Cre-ERT technology is based on an enzyme called Cre recombinase. This enzyme is able to recombine specific sequences of DNA called loxP. Upon encountering two separate loxP sites flanking a target nucleotide sequence, Cre recombinase deletes this intervening sequence by an irreversible recombination event between the loxP sites. By excision of a loxP flanked (floxed) critical region of a gene, the gene can be conditionally knocked out only after Cre is expressed. The spatial control of the conditional knock-out can be achieved by driving Cre activity under a tissue-specific promoter in transgenic mice. In order to generate an inducible knock-out, the Cre enzyme has been fused to a mutated ligand-binding domain of the human estrogen receptor (ERT). Upon the introduction of the synthetic estrogen receptor antagonist tamoxifen, the Cre-ERT construct enters the nucleus and induces the targeted mutation. ERT binds tamoxifen but not to endogenous estrogens, which allows Cre-ERT to remain cytoplasmic in animals that are not treated with tamoxifen. The temporal control by tamoxifen permits to study gene function at the desired time. This can help to elucidate the gene function in adults which is important for drug discovery and basic research.

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.

Latest Stories
Enterprises have taken advantage of IoT to achieve important revenue and cost advantages. What is less apparent is how incumbent enterprises operating at scale have, following success with IoT, built analytic, operations management and software development capabilities - ranging from autonomous vehicles to manageable robotics installations. They have embraced these capabilities as if they were Silicon Valley startups.
"MobiDev is a Ukraine-based software development company. We do mobile development, and we're specialists in that. But we do full stack software development for entrepreneurs, for emerging companies, and for enterprise ventures," explained Alan Winters, U.S. Head of Business Development at MobiDev, in this SYS-CON.tv interview at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
The Internet of Things is clearly many things: data collection and analytics, wearables, Smart Grids and Smart Cities, the Industrial Internet, and more. Cool platforms like Arduino, Raspberry Pi, Intel's Galileo and Edison, and a diverse world of sensors are making the IoT a great toy box for developers in all these areas. In this Power Panel at @ThingsExpo, moderated by Conference Chair Roger Strukhoff, panelists discussed what things are the most important, which will have the most profound e...
Digital Transformation is well underway with many applications already on the cloud utilizing agile and devops methodologies. Unfortunately, application security has been an afterthought and data breaches have become a daily occurrence. Security is not one individual or one's team responsibility. Raphael Reich will introduce you to DevSecOps concepts and outline how to seamlessly interweave security principles across your software development lifecycle and application lifecycle management. With ...
With more than 30 Kubernetes solutions in the marketplace, it's tempting to think Kubernetes and the vendor ecosystem has solved the problem of operationalizing containers at scale or of automatically managing the elasticity of the underlying infrastructure that these solutions need to be truly scalable. Far from it. There are at least six major pain points that companies experience when they try to deploy and run Kubernetes in their complex environments. In this presentation, the speaker will d...
Dhiraj Sehgal works in Delphix's product and solution organization. His focus has been DevOps, DataOps, private cloud and datacenters customers, technologies and products. He has wealth of experience in cloud focused and virtualized technologies ranging from compute, networking to storage. He has spoken at Cloud Expo for last 3 years now in New York and Santa Clara.
Your job is mostly boring. Many of the IT operations tasks you perform on a day-to-day basis are repetitive and dull. Utilizing automation can improve your work life, automating away the drudgery and embracing the passion for technology that got you started in the first place. In this presentation, I'll talk about what automation is, and how to approach implementing it in the context of IT Operations. Ned will discuss keys to success in the long term and include practical real-world examples. Ge...
As IoT continues to increase momentum, so does the associated risk. Secure Device Lifecycle Management (DLM) is ranked as one of the most important technology areas of IoT. Driving this trend is the realization that secure support for IoT devices provides companies the ability to deliver high-quality, reliable, secure offerings faster, create new revenue streams, and reduce support costs, all while building a competitive advantage in their markets. In this session, we will use customer use cases...
Bill Schmarzo, author of "Big Data: Understanding How Data Powers Big Business" and "Big Data MBA: Driving Business Strategies with Data Science," is responsible for setting the strategy and defining the Big Data service offerings and capabilities for EMC Global Services Big Data Practice. As the CTO for the Big Data Practice, he is responsible for working with organizations to help them identify where and how to start their big data journeys. He's written several white papers, is an avid blogge...
When talking IoT we often focus on the devices, the sensors, the hardware itself. The new smart appliances, the new smart or self-driving cars (which are amalgamations of many ‘things'). When we are looking at the world of IoT, we should take a step back, look at the big picture. What value are these devices providing. IoT is not about the devices, its about the data consumed and generated. The devices are tools, mechanisms, conduits. This paper discusses the considerations when dealing with the...
Wooed by the promise of faster innovation, lower TCO, and greater agility, businesses of every shape and size have embraced the cloud at every layer of the IT stack – from apps to file sharing to infrastructure. The typical organization currently uses more than a dozen sanctioned cloud apps and will shift more than half of all workloads to the cloud by 2018. Such cloud investments have delivered measurable benefits. But they’ve also resulted in some unintended side-effects: complexity and risk. ...
Sanjeev Sharma Joins November 11-13, 2018 @DevOpsSummit at @CloudEXPO New York Faculty. Sanjeev Sharma is an internationally known DevOps and Cloud Transformation thought leader, technology executive, and author. Sanjeev's industry experience includes tenures as CTO, Technical Sales leader, and Cloud Architect leader. As an IBM Distinguished Engineer, Sanjeev is recognized at the highest levels of IBM's core of technical leaders.
Business professionals no longer wonder if they'll migrate to the cloud; it's now a matter of when. The cloud environment has proved to be a major force in transitioning to an agile business model that enables quick decisions and fast implementation that solidify customer relationships. And when the cloud is combined with the power of cognitive computing, it drives innovation and transformation that achieves astounding competitive advantage.
Jo Peterson is VP of Cloud Services for Clarify360, a boutique sourcing and benchmarking consultancy focused on transforming technology into business advantage. Clarify360 provides custom, end-to-end solutions from a portfolio of more than 170 suppliers globally. As an engineer, Jo sources net new technology footprints, and is an expert at optimizing and benchmarking existing environments focusing on Cloud Enablement and Optimization. She and her team work with clients on Cloud Discovery, Cloud ...
This is going to be a live demo on a production ready CICD pipeline which automate the deployment of application onto AWS ECS and Fargate. The same pipeline will automate deployment into various environment such as Test, UAT, and Prod. The pipeline will go through various stages such as source, build, test, approval, UAT stage, Prod stage. The demo will utilize only AWS services including AWS CodeCommit, Codebuild, code pipeline, Elastic container service (ECS), ECR, and Fargate.